PHARMARESEARCH BIO Co., Ltd. (XKON:217950)

South Korea flag South Korea · Delayed Price · Currency is KRW
34,250
-650 (-1.86%)
At close: Aug 1, 2025, 3:30 PM KST
-1.86%
Market Cap143.19B
Revenue (ttm)178.19M
Net Income (ttm)-883.52M
Shares Out4.18M
EPS (ttm)-22,088.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,992
Average Volume2,873
Open35,200
Previous Close34,900
Day's Range33,900 - 35,200
52-Week Range23,750 - 50,000
Beta0.24
RSI30.82
Earnings Daten/a

About Aspen Technology

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 217950
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.